用于2型糖尿病治疗的选择性过氧化物酶体增殖物激活受体γ调节剂：我们已经取得了哪些进展，未来又将如何？ - Suppr

Selective PPARγ modulators for Type 2 diabetes treatment: how far have we come and what does the future hold?

作者信息

Lavecchia Antonio, Cerchia Carmen

机构信息

Department of Pharmacy, 'Drug Discovery' Laboratory, University of Napoli 'Federico II', Via D. Montesano, 49, 80131, Napoli, Italy.

出版信息

Future Med Chem. 2018 Apr 1;10(7):703-705. doi: 10.4155/fmc-2018-0021. Epub 2018 Apr 19.

DOI:10.4155/fmc-2018-0021

PMID:29671628

Abstract

摘要

相似文献

Selective PPARγ modulators for Type 2 diabetes treatment: how far have we come and what does the future hold?

Future Med Chem. 2018 Apr 1;10(7):703-705. doi: 10.4155/fmc-2018-0021. Epub 2018 Apr 19.

Design, synthesis, and activity evaluation of GK/PPARγ dual-target-directed ligands as hypoglycemic agents.

ChemMedChem. 2014 May;9(5):922-7. doi: 10.1002/cmdc.201400009. Epub 2014 Apr 15.

Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome.

Eur J Med Chem. 2019 Jul 1;173:261-273. doi: 10.1016/j.ejmech.2019.04.030. Epub 2019 Apr 13.

Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators.

J Med Chem. 2011 Dec 22;54(24):8541-54. doi: 10.1021/jm201061j. Epub 2011 Nov 28.

Multitargeted bioactive ligands for PPARs discovered in the last decade.

Chem Biol Drug Des. 2016 Nov;88(5):635-663. doi: 10.1111/cbdd.12806. Epub 2016 Jul 21.

A review on the development in the field of NIDDM based thiazolidinedione PPARγ agonists.

Mini Rev Med Chem. 2013 Apr 1;13(5):706-12. doi: 10.2174/1389557511313050007.

Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds.

Molecules. 2018 Sep 22;23(10):2431. doi: 10.3390/molecules23102431.

Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPARγ modulators.

Eur J Med Chem. 2012 Aug;54:522-33. doi: 10.1016/j.ejmech.2012.05.040. Epub 2012 Jun 7.

Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists.

Mol Pharmacol. 2012 Jul;82(1):68-79. doi: 10.1124/mol.111.076679. Epub 2012 Apr 10.

Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency.

Sci Rep. 2015 Jul 17;5:12222. doi: 10.1038/srep12222.

引用本文的文献

From Apo to Ligand-Bound: Unraveling PPARγ-LBD Conformational Shifts via Advanced Molecular Dynamics.

ACS Omega. 2025 Feb 17;10(13):13303-13318. doi: 10.1021/acsomega.4c11128. eCollection 2025 Apr 8.

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.

Pharmacol Rev. 2023 Nov;75(6):1233-1318. doi: 10.1124/pharmrev.121.000436. Epub 2023 Aug 16.

The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity.

Front Nutr. 2022 Jun 13;9:913883. doi: 10.3389/fnut.2022.913883. eCollection 2022.

A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).

Molecules. 2022 Jan 31;27(3):958. doi: 10.3390/molecules27030958.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Selective PPARγ modulators for Type 2 diabetes treatment: how far have we come and what does the future hold?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Selective PPARγ modulators for Type 2 diabetes treatment: how far have we come and what does the future hold?

作者信息

机构信息

出版信息

相似文献

引用本文的文献